| FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer T Conroy, P Hammel, M Hebbar, M Ben Abdelghani, AC Wei, JL Raoul, ... New England Journal of Medicine 379 (25), 2395-2406, 2018 | 2418 | 2018 |
| Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes SA Shah, SP Cleary, AC Wei, I Yang, BR Taylor, AW Hemming, B Langer, ... Surgery 141 (3), 330-339, 2007 | 467 | 2007 |
| Survival after hepatic resection for colorectal metastases: a 10-year experience AC Wei, PD Greig, D Grant, B Taylor, B Langer, S Gallinger Annals of surgical oncology 13, 668-676, 2006 | 459 | 2006 |
| Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma AC Wei, R Tung-Ping Poon, ST Fan, J Wong Journal of British Surgery 90 (1), 33-41, 2003 | 383 | 2003 |
| Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma SA Shah, R Haddad, W Al-Sukhni, RD Kim, PD Greig, DR Grant, ... Journal of the American College of Surgeons 202 (3), 468-475, 2006 | 318 | 2006 |
| Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ... Nature 618 (7963), 144-150, 2023 | 281 | 2023 |
| Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma C Toso, J Trotter, A Wei, DL Bigam, S Shah, J Lancaster, DR Grant, ... Liver Transplantation 14 (8), 1107-1115, 2008 | 279 | 2008 |
| Effect of combined immune checkpoint inhibition vs best supportive care alone in patients with advanced colorectal cancer: the Canadian Cancer Trials Group CO. 26 Study EX Chen, DJ Jonker, JM Loree, HF Kennecke, SR Berry, F Couture, ... JAMA oncology 6 (6), 831-838, 2020 | 269 | 2020 |
| AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AG Singal, JM Llovet, M Yarchoan, N Mehta, JK Heimbach, LA Dawson, ... Hepatology 78 (6), 1922-1965, 2023 | 217 | 2023 |
| A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer EJ Kim, E Ben‐Josef, JM Herman, T Bekaii‐Saab, LA Dawson, KA Griffith, ... Cancer 119 (15), 2692-2700, 2013 | 203 | 2013 |
| Unicancer GI PRODIGE 24/CCTG PA. 6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected … T Conroy, P Hammel, M Hebbar, M Ben Abdelghani, AC Wei, JL Raoul, ... Journal of Clinical Oncology 36 (18_suppl), LBA4001-LBA4001, 2018 | 190 | 2018 |
| Enhanced recovery after pancreatic surgery: a systematic review of the evidence DJ Kagedan, M Ahmed, KS Devitt, AC Wei Hpb 17 (1), 11-16, 2015 | 189 | 2015 |
| Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment, and outcome CHL Law, AC Wei, SS Hanna, M Al-Zahrani, BR Taylor, PD Greig, ... Annals of surgical oncology 10, 922-926, 2003 | 181 | 2003 |
| Bile duct injuries associated with laparoscopic cholecystectomy: timing of repair and long-term outcomes AK Sahajpal, SC Chow, E Dixon, PD Greig, S Gallinger, AC Wei Archives of Surgery 145 (8), 757-763, 2010 | 150 | 2010 |
| Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial DJ Jonker, L Nott, T Yoshino, S Gill, J Shapiro, A Ohtsu, J Zalcberg, ... The lancet Gastroenterology & hepatology 3 (4), 263-270, 2018 | 145 | 2018 |
| The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review D Quan, S Gallinger, C Nhan, RA Auer, JJ Biagi, GG Fletcher, CHL Law, ... Surgery 151 (6), 860-870, 2012 | 137 | 2012 |
| An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution SA Shah, SP Cleary, JCC Tan, AC Wei, S Gallinger, DR Grant, PD Greig Annals of surgical oncology 14, 2608-2614, 2007 | 117 | 2007 |
| Prognosis and results after resection of very large (≥ 10 cm) hepatocellular carcinoma SA Shah, AC Wei, SP Cleary, I Yang, ID McGilvray, S Gallinger, DR Grant, ... Journal of Gastrointestinal Surgery 11 (5), 589-595, 2007 | 105 | 2007 |
| Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial T Conroy, F Castan, A Lopez, A Turpin, MB Abdelghani, AC Wei, E Mitry, ... JAMA oncology 8 (11), 1571-1578, 2022 | 104 | 2022 |
| Comparison of outcomes and costs between laparoscopic distal pancreatectomy and open resection at a single center AM Fox, K Pitzul, F Bhojani, M Kaplan, CA Moulton, AC Wei, I McGilvray, ... Surgical endoscopy 26, 1220-1230, 2012 | 94 | 2012 |
